Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. [electronic resource]
Producer: 20180306ISSN:- 2047-9980
- Australia
- Brain Ischemia -- diagnosis
- Canada
- Combined Modality Therapy
- Cost Savings
- Cost-Benefit Analysis
- Disability Evaluation
- Endovascular Procedures -- adverse effects
- Europe
- Fibrinolytic Agents -- administration & dosage
- Health Care Costs
- Health Resources -- economics
- Humans
- Infusions, Intravenous
- Length of Stay -- economics
- Process Assessment, Health Care -- economics
- Prospective Studies
- Quality-Adjusted Life Years
- Stroke -- diagnosis
- Thrombolytic Therapy -- adverse effects
- Time Factors
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.